cancer	is a	malignant neoplasm
smoking	increases	cancer risk
radon exposure	increases	lung cancer risk
asbestos exposure	increases	mesothelioma risk
age	increases	cancer incidence
genetic mutation	predisposes to	cancer
EGFR mutation	predicts response to	EGFR inhibitors
KRAS mutation	predicts resistance to	EGFR inhibitors
ALK fusion	predicts response to	ALK inhibitors
PD-L1 expression	predicts response to	immunotherapy
tumor mutational burden	predicts response to	immunotherapy
lung cancer	metastasizes to	brain
lung cancer	metastasizes to	bone
lung cancer	metastasizes to	liver
pleural effusion	accompanies	lung cancer
bone metastasis	causes	pain
brain metastasis	causes	neurological deficits
cough	is symptom of	lung cancer
dyspnea	is symptom of	lung cancer
weight loss	is symptom of	cancer
hoarseness	is symptom of	lung cancer
biopsy	confirms	cancer
imaging	shows	mass
CT scan	detects	mass
PET-CT	detects	metastasis
histology	classifies	cancer type
adenocarcinoma	is subtype of	non-small cell lung cancer
squamous cell carcinoma	is subtype of	non-small cell lung cancer
small cell lung cancer	is type of	lung cancer
mesothelioma	arises from	pleura
pleura	is lined by	mesothelium
tumor size	correlates with	prognosis
nodal involvement	worsens	prognosis
stage	determines	treatment plan
TNM stage	correlates with	prognosis
staging	guides	therapy selection
surgery	increases	cure rate
radiation therapy	used for	palliation
chemotherapy	used for	non-small cell lung cancer
immunotherapy	used for	cancer
targeted therapy	used for	mutation-positive cancer
neutropenia	is side effect of	chemotherapy
nausea	is side effect of	chemotherapy
anemia	is complication of	cancer
infection	occurs with	immunosuppressed cancer patients
radiation therapy	causes	esophagitis
pneumonitis	occurs with	immunotherapy
immunotherapy	causes	pneumonitis
pneumonitis	managed with	corticosteroids
palliative care	improves	quality of life
quality of life	influences	overall survival
overall survival	depends on	stage
smoking cessation	reduces	cancer risk
air pollution	increases	lung cancer risk
occupational exposure	increases	lung cancer risk
COPD	coexists with	lung cancer
pneumonia	complicates	cancer treatment
cachexia	occurs in	cancer patients
paraneoplastic syndrome	occurs with	cancer
bone pain	indicates	metastasis
anxiety	accompanies	cancer diagnosis
hemoptysis	occurs with	lung cancer
hoarseness	due to	recurrent laryngeal nerve invasion
mediastinal mass	compresses	superior vena cava
superior vena cava syndrome	treated with	stenting
stenting	relieves	venous obstruction
bronchoscopy	aids	diagnosis
biopsy	guides	therapy
pathology	confirms	cancer type
tumor board	coordinates	multidisciplinary care
blood tests	indicate	cancer presence
MRI	evaluates	thoracic tumor
CT-guided biopsy	obtains	tissue sample
tissue biopsy	confirms	malignancy
brain metastasis	causes	seizures
bone metastasis	causes	hypercalcemia
hypoxemia	results from	lung cancer
tumor marker	used for	monitoring cancer
checkpoint inhibitor	targets	PD-1 pathway
PD-1 pathway	is target of	checkpoint inhibitors
EGFR tyrosine kinase inhibitor	treats	EGFR-mutant cancer
osimertinib	treats	EGFR-mutant cancer
immunotherapy	can cause	immune-related adverse events
cancer	increases	hospital admissions
hospital admission	indicates	disease severity
readmission	associated with	cancer therapy
neoadjuvant therapy	precedes	surgery
adjuvant therapy	follows	surgery
clinical trial	tests	new therapy
randomized trial	demonstrates	survival benefit
tumor burden	correlates with	prognosis
tumor recurrence	occurs after	therapy
complications	increase	length of stay
hemoptysis	indicates	tumor bleeding
neutropenia	increases risk of	infection
hypoxia	worsens	prognosis
thoracentesis	relieves	dyspnea
radiologic progression	signals	treatment failure
biomarker	informs	prognosis
oncologist	coordinates	cancer care
